Business Context and Reporting Period
Company: Forestar Group Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 13, 2017
Primary Event: Entry into a definitive merger agreement with Terra Firma Merger Parent, L.P. and Terra Firma Merger Sub, L.P., affiliates of Starwood Capital Group.
Key Financial Metrics and Transaction Terms
This filing details a proposed acquisition rather than periodic financial performance. Key financial terms include:
- Merger Consideration: $14.25 per share in cash for each outstanding share of Forestar common stock.
- Equity Awards: Outstanding equity awards will be cancelled and converted to cash based on the $14.25 per share consideration (less strike price for options, if applicable).
- Termination Fees (Forestar to Parent):
- $20,000,000 if the Board changes its recommendation or Forestar accepts a superior proposal.
- Up to $4,000,000 for expenses if terminated due to shareholder disapproval or material breach by Forestar.
- $3,000,000 for expenses if terminated due to failure to consummate divestitures or meet minimum proceeds.
- Termination Fee (Parent to Forestar): $40,000,000 if Parent terminates due to material breach by Forestar or fails to close within two business days of the scheduled date.
- Executive Separation Costs: A lump-sum cash payment of $550,000 to departing Chief Administrative Officer David M. Grimm, plus medical reimbursement, outplacement expenses (up to $25,000), and potential change-in-control benefits.
Financial Performance: The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.
Material Changes and Conditions
The filing announces a material change in corporate structure via the Merger Agreement. Consummation is subject to several conditions:
- Approval by holders of a majority of outstanding shares.
- Absence of laws or orders prohibiting the merger.
- Dissenting shares representing less than 20% of outstanding shares.
- Consummation of certain asset disposition transactions by Forestar.
- Absence of a "Company Material Adverse Effect."
- Outside Date: The agreement may be terminated if the merger is not consummated by October 10, 2017.
Guidance, Outlook, and Risks
Management Commentary: The Board has approved the transaction and recommends shareholder approval. The company has agreed to conduct business in the ordinary course and not solicit alternative proposals, subject to exceptions.
Risks and Contingencies:
- Failure to satisfy closing conditions, including shareholder approval.
- Potential material adverse change in Forestar's business due to transaction uncertainty.
- Unexpected costs, liabilities, or delays.
- Legal proceedings related to the transaction.
- Changes in economic, political, or regulatory conditions.
Corporate Governance Changes:
- Bylaw Amendment: Added a provision designating the Court of Chancery of the State of Delaware as the exclusive forum for certain corporate disputes.
- Tax Benefits Plan: Amended to exempt the merger transaction from triggering the poison pill provisions.
Investor Verification Checklist
- Verify the final vote count at the special shareholder meeting to ensure the majority approval condition is met.
- Confirm the status of the required asset disposition transactions and whether minimum proceeds have been achieved.
- Review the definitive proxy statement (Schedule 14A) for detailed financial data and risk factors not included in this 8-K.
- Monitor for any "superior proposals" that could trigger the $20 million termination fee or alter the transaction terms.
- Check for any regulatory approvals or legal challenges that could delay or block the closing before the October 10, 2017 Outside Date.